{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:50:08Z","timestamp":1792673408524,"version":"4.5.0"},"reference-count":45,"publisher":"American Association for Cancer Research (AACR)","issue":"15","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Exposure to tobacco smoke is associated with increased DNA methylation at certain genes in both lung and bladder tumors. We sought to identify interactions in bladder cancer between DNA methylation and a history of smoking, along with any possible effect of aging. We measured DNA methylation in 342 transitional cell carcinoma tumors at BCL2, PTGS2 (COX2), DAPK, CDH1 (ECAD), EDNRB, RASSF1A, RUNX3, TERT, and TIMP3. The prevalence of methylation at RUNX3, a polycomb target gene, increased as a function of age at diagnosis (P = 0.031) and a history of smoking (P = 0.015). RUNX3 methylation also preceded methylation at the other eight genes (P &amp;lt; 0.001). It has been proposed that DNA methylation patterns constitute a \u201cmolecular clock\u201d and can be used to determine the \u201cage\u201d of normal tissues (i.e., the number of times the cells have divided). Because RUNX3 methylation increases with age, is not present in normal urothelium, and occurs early in tumorigenesis, it can be used for the first time as a molecular clock to determine the age of a bladder tumor. Doing so reveals that tumors from smokers are \u201colder\u201d than tumors from nonsmokers (P = 0.009) due to tumors in smokers either initiating earlier or undergoing more rapid cell divisions. Because RUNX3 methylation is acquired early on in tumorigenesis, then its detection in biopsy or urine specimens could provide a marker to screen cigarette smokers long before any symptoms of bladder cancer are present. [Cancer Res 2008;68(15):6208\u201314]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-6616","type":"journal-article","created":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T13:58:13Z","timestamp":1217599093000},"page":"6208-6214","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["<i>RUNX3<\/i>\n                    Methylation Reveals that Bladder Tumors Are Older in Patients with a History of Smoking"],"prefix":"10.1158","volume":"68","author":[{"given":"Erika M.","family":"Wolff","sequence":"first","affiliation":[{"name":"1Urology and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangning","family":"Liang","sequence":"additional","affiliation":[{"name":"1Urology and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie C.","family":"Cortez","sequence":"additional","affiliation":[{"name":"1Urology and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne C.","family":"Tsai","sequence":"additional","affiliation":[{"name":"1Urology and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Esteban","family":"Castelao","sequence":"additional","affiliation":[{"name":"2Preventive Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria K.","family":"Cortessis","sequence":"additional","affiliation":[{"name":"2Preventive Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denice D.","family":"Tsao-Wei","sequence":"additional","affiliation":[{"name":"2Preventive Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Groshen","sequence":"additional","affiliation":[{"name":"2Preventive Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Jones","sequence":"additional","affiliation":[{"name":"1Urology and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2008,8,1]]},"reference":[{"key":"2022061700403151900_B1","doi-asserted-by":"crossref","unstructured":"Feinberg AP. The epigenetics of cancer etiology. Semin Cancer Biol\u20082004; 14: 427\u201332.","DOI":"10.1016\/j.semcancer.2004.06.005"},{"key":"2022061700403151900_B2","doi-asserted-by":"crossref","unstructured":"Herceg Z. Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors. Mutagenesis\u20082007; 22: 91\u2013103.","DOI":"10.1093\/mutage\/gel068"},{"key":"2022061700403151900_B3","doi-asserted-by":"crossref","unstructured":"Jones PA, Baylin SB. The epigenomics of cancer. Cell\u20082007; 128: 683\u201392.","DOI":"10.1016\/j.cell.2007.01.029"},{"key":"2022061700403151900_B4","doi-asserted-by":"crossref","unstructured":"Miranda TB, Jones PA. DNA methylation: the nuts and bolts of repression. J Cell Physiol\u20082007; 213: 384\u201390.","DOI":"10.1002\/jcp.21224"},{"key":"2022061700403151900_B5","doi-asserted-by":"crossref","unstructured":"Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet\u20082002; 3: 415\u201328.","DOI":"10.1038\/nrg816"},{"key":"2022061700403151900_B6","doi-asserted-by":"crossref","unstructured":"Fraga MF, Ballestar E, Paz MF, et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A\u20082005; 102: 10604\u20139.","DOI":"10.1073\/pnas.0500398102"},{"key":"2022061700403151900_B7","unstructured":"Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JP. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res\u20081998; 58: 5489\u201394."},{"key":"2022061700403151900_B8","doi-asserted-by":"crossref","unstructured":"Kim JY, Siegmund KD, Tavare S, Shibata D. Age-related human small intestine methylation: evidence for stem cell niches. BMC Med\u20082005; 3: 10.","DOI":"10.1186\/1741-7015-3-10"},{"key":"2022061700403151900_B9","unstructured":"Kim DH, Nelson HH, Wiencke JK, et al. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res\u20082001; 61: 3419\u201324."},{"key":"2022061700403151900_B10","unstructured":"Anttila S, Hakkola J, Tuominen P, et al. Methylation of cytochrome P4501A1 promoter in the lung is associated with tobacco smoking. Cancer Res\u20082003; 63: 8623\u20138."},{"key":"2022061700403151900_B11","unstructured":"Kim DH, Kim JS, Ji YI, et al. Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer. Cancer Res\u20082003; 63: 3743\u20136."},{"key":"2022061700403151900_B12","doi-asserted-by":"crossref","unstructured":"Marsit CJ, Karagas MR, Danaee H, et al. Carcinogen exposure and gene promoter hypermethylation in bladder cancer. Carcinogenesis\u20082006; 27: 112\u20136.","DOI":"10.1093\/carcin\/bgi172"},{"key":"2022061700403151900_B13","doi-asserted-by":"crossref","unstructured":"Marsit CJ, Houseman EA, Schned AR, Karagas MR, Kelsey KT. Promoter hypermethylation is associated with current smoking, age, gender, and survival in bladder cancer. Carcinogenesis\u20082007; 28: 1745\u201351.","DOI":"10.1093\/carcin\/bgm116"},{"key":"2022061700403151900_B14","doi-asserted-by":"crossref","unstructured":"Widschwendter M, Fiegl H, Egle D, et al. Epigenetic stem cell signature in cancer. Nat Genet\u20082007; 39: 157\u20138.","DOI":"10.1038\/ng1941"},{"key":"2022061700403151900_B15","doi-asserted-by":"crossref","unstructured":"Schlesinger Y, Straussman R, Keshet I, et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet\u20082007; 39: 232\u20136.","DOI":"10.1038\/ng1950"},{"key":"2022061700403151900_B16","doi-asserted-by":"crossref","unstructured":"Ohm JE, McGarvey KM, Yu X, et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet\u20082007; 39: 237\u201342.","DOI":"10.1038\/ng1972"},{"key":"2022061700403151900_B17","doi-asserted-by":"crossref","unstructured":"Wolff EM, Liang G, Jones PA. Mechanisms of disease: genetic and epigenetic alterations that drive bladder cancer. Nat Clin Pract Urol\u20082005; 2: 502\u201310.","DOI":"10.1038\/ncpuro0318"},{"key":"2022061700403151900_B18","doi-asserted-by":"crossref","unstructured":"Castelao JE, Yuan JM, Skipper PL, et al. Gender- and smoking-related bladder cancer risk. J Natl Cancer Inst\u20082001; 93: 538\u201345.","DOI":"10.1093\/jnci\/93.7.538"},{"key":"2022061700403151900_B19","doi-asserted-by":"crossref","unstructured":"Eads CA, Danenberg KD, Kawakami K, et al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res\u20082000; 28: E32.","DOI":"10.1093\/nar\/28.8.e32"},{"key":"2022061700403151900_B20","doi-asserted-by":"crossref","unstructured":"Suzuki M, Shigematsu H, Shames DS, et al. DNA methylation-associated inactivation of TGF\u03b2-related genes DRM\/Gremlin, RUNX3, and HPP1 in human cancers. Br J Cancer\u20082005; 93: 1029\u201337.","DOI":"10.1038\/sj.bjc.6602837"},{"key":"2022061700403151900_B21","doi-asserted-by":"crossref","unstructured":"Kim WJ, Kim EJ, Jeong P, et al. RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors. Cancer Res\u20082005; 65: 9347\u201354.","DOI":"10.1158\/0008-5472.CAN-05-1647"},{"key":"2022061700403151900_B22","doi-asserted-by":"crossref","unstructured":"Schwartz YB, Kahn TG, Nix DA, et al. Genome-wide analysis of Polycomb targets in Drosophila melanogaster. Nat Genet\u20082006; 38: 700\u20135.","DOI":"10.1038\/ng1817"},{"key":"2022061700403151900_B23","doi-asserted-by":"crossref","unstructured":"Ringrose L. Polycomb comes of age: genome-wide profiling of target sites. Curr Opin Cell Biol\u20082007; 19: 290\u20137.","DOI":"10.1016\/j.ceb.2007.04.010"},{"key":"2022061700403151900_B24","doi-asserted-by":"crossref","unstructured":"Fujii S, Ito K, Ito Y, Ochiai A. Enhancer of zeste homologue 2 (EZH2) down-regulates RUNX3 by increasing histone H3 methylation. J Biol Chem 2008.","DOI":"10.1074\/jbc.M800224200"},{"key":"2022061700403151900_B25","doi-asserted-by":"crossref","unstructured":"Byun HM, Wong HL, Birnstein EA, Wolff EM, Liang G, Yang AS. Examination of IGF2 and H19 loss of imprinting in bladder cancer. Cancer Res\u20082007; 67: 10753\u20138.","DOI":"10.1158\/0008-5472.CAN-07-0329"},{"key":"2022061700403151900_B26","doi-asserted-by":"crossref","unstructured":"Friedrich MG, Weisenberger DJ, Cheng JC, et al. Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients. Clin Cancer Res\u20082004; 10: 7457\u201365.","DOI":"10.1158\/1078-0432.CCR-04-0930"},{"key":"2022061700403151900_B27","doi-asserted-by":"crossref","unstructured":"Widschwendter M, Siegmund KD, Muller HM, et al. Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen. Cancer Res\u20082004; 64: 3807\u201313.","DOI":"10.1158\/0008-5472.CAN-03-3852"},{"key":"2022061700403151900_B28","unstructured":"Eads CA, Lord RV, Kurumboor SK, et al. Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res\u20082000; 60: 5021\u20136."},{"key":"2022061700403151900_B29","unstructured":"Eads CA, Lord RV, Wickramasinghe K, et al. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res\u20082001; 61: 3410\u20138."},{"key":"2022061700403151900_B30","doi-asserted-by":"crossref","unstructured":"Gonzalgo ML, Liang G. Methylation-sensitive single-nucleotide primer extension (Ms-SNuPE) for quantitative measurement of DNA methylation. Nat Protoc\u20082007; 2: 1931\u20136.","DOI":"10.1038\/nprot.2007.271"},{"key":"2022061700403151900_B31","doi-asserted-by":"crossref","unstructured":"Weisenberger DJ, Siegmund KD, Campan M, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet\u20082006; 38: 787\u201393.","DOI":"10.1038\/ng1834"},{"key":"2022061700403151900_B32","unstructured":"SAS Institute, Inc. The Loess procedure. SAS\/STAT user's guide, version 8. Cary (NC): SAS Publishing; 2000. p. 1853\u2013900."},{"key":"2022061700403151900_B33","doi-asserted-by":"crossref","unstructured":"Kang GH, Lee S, Lee HJ, Hwang KS. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia. J Pathol\u20082004; 202: 233\u201340.","DOI":"10.1002\/path.1503"},{"key":"2022061700403151900_B34","doi-asserted-by":"crossref","unstructured":"Kim TY, Lee HJ, Hwang KS, et al. Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma. Lab Invest\u20082004; 84: 479\u201384.","DOI":"10.1038\/labinvest.3700060"},{"key":"2022061700403151900_B35","doi-asserted-by":"crossref","unstructured":"Waki T, Tamura G, Sato M, Terashima M, Nishizuka S, Motoyama T. Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia. Cancer Sci\u20082003; 94: 360\u20134.","DOI":"10.1111\/j.1349-7006.2003.tb01447.x"},{"key":"2022061700403151900_B36","doi-asserted-by":"crossref","unstructured":"Lau QC, Raja E, Salto-Tellez M, et al. RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer. Cancer Res\u20082006; 66: 6512\u201320.","DOI":"10.1158\/0008-5472.CAN-06-0369"},{"key":"2022061700403151900_B37","doi-asserted-by":"crossref","unstructured":"Yanagawa N, Tamura G, Oizumi H, Takahashi N, Shimazaki Y, Motoyama T. Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers. Cancer Sci\u20082003; 94: 589\u201392.","DOI":"10.1111\/j.1349-7006.2003.tb01487.x"},{"key":"2022061700403151900_B38","doi-asserted-by":"crossref","unstructured":"Park WS, Cho YG, Kim CJ, et al. Hypermethylation of the RUNX3 gene in hepatocellular carcinoma. Exp Mol Med\u20082005; 37: 276\u201381.","DOI":"10.1038\/emm.2005.37"},{"key":"2022061700403151900_B39","doi-asserted-by":"crossref","unstructured":"Subramaniam MM, Chan JY, Soong R, et al. RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression. Breast Cancer Res Treat 2008.","DOI":"10.1007\/s10549-008-9917-4"},{"key":"2022061700403151900_B40","doi-asserted-by":"crossref","unstructured":"Schulmann K, Sterian A, Berki A, et al. Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk. Oncogene\u20082005; 24: 4138\u201348.","DOI":"10.1038\/sj.onc.1208598"},{"key":"2022061700403151900_B41","doi-asserted-by":"crossref","unstructured":"Lancelin F, Anidjar M, Villette JM, et al. Telomerase activity as a potential marker in preneoplastic bladder lesions. BJU Int\u20082000; 85: 526\u201331.","DOI":"10.1046\/j.1464-410x.2000.00466.x"},{"key":"2022061700403151900_B42","doi-asserted-by":"crossref","unstructured":"Kavaler E, Landman J, Chang Y, Droller MJ, Liu BC. Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity. Cancer\u20081998; 82: 708\u201314.","DOI":"10.1002\/(SICI)1097-0142(19980215)82:4<708::AID-CNCR14>3.0.CO;2-1"},{"key":"2022061700403151900_B43","doi-asserted-by":"crossref","unstructured":"Luebeck EG, Moolgavkar SH. Multistage carcinogenesis and the incidence of colorectal cancer. Proc Natl Acad Sci U S A\u20082002; 99: 15095\u2013100.","DOI":"10.1073\/pnas.222118199"},{"key":"2022061700403151900_B44","unstructured":"Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE. Increased cell division as a cause of human cancer. Cancer Res\u20081990; 50: 7415\u201321."},{"key":"2022061700403151900_B45","doi-asserted-by":"crossref","unstructured":"Li Q, Jedlicka A, Ahuja N, et al. Concordant methylation of the ER and N33 genes in glioblastoma multiforme. Oncogene\u20081998; 16: 3197\u2013202.","DOI":"10.1038\/sj.onc.1201831"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/15\/6208\/2595395\/6208.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/15\/6208\/2595395\/6208.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T02:03:02Z","timestamp":1655431382000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/68\/15\/6208\/541040\/RUNX3-Methylation-Reveals-that-Bladder-Tumors-Are"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,1]]},"references-count":45,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2008,8,1]]},"published-print":{"date-parts":[[2008,8,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-6616","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,1]]}}}